MEDI4736 Alone and in Combination With Tremelimumab or AZD9150 in Adult Subjects With Relapsed/Refractory DLBCL (D4190C00023)
Clinical trial NCT02549651 · COMPLETED
Trial details
- NCT number
- NCT02549651
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-13
- Primary completion
- 2019-02-04
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.